Article
Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study.
Lupus science & medicine - 1 Jul 2025
Ye Chen, Liu Baojing, Chen Lizhi, Zhang Lu, Zheng Yifan, Tang Kejing, Jiang Xiaoyun, Chen Pan
Abstract excerpt
BACKGROUND: Mycophenolic acid (MPA) is recommended for the treatment of lupus nephritis (LN). However, the high pharmacokinetic (PK) variability of MPA contributes to its suboptimal efficacy and an increased incidence of adverse reactions. Rare data reported the impacts of genetic and clinical characteristics on MPA clearance in the paediatric patients with LN. METHODS: Paediatric patients with LN receiving...
Read the complete abstract on PubMedTopics
- Humans
- Mycophenolic Acid
- Lupus Nephritis
- Child
- Female
- Male
- Adolescent
